UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$7,985,938
-2.5%
208,184
+49.4%
0.00%
-33.3%
Q1 2024$8,189,523
-3.5%
139,325
-1.7%
0.00%0.0%
Q4 2023$8,486,233
+52.9%
141,768
-2.9%
0.00%
+50.0%
Q3 2023$5,551,785
-15.7%
145,946
+46.2%
0.00%
-33.3%
Q2 2023$6,583,0720.0%99,8040.0%0.00%0.0%
Q1 2023$6,583,072
+69.5%
99,804
+32.9%
0.00%
+50.0%
Q4 2022$3,882,696
-99.9%
75,086
+8.6%
0.00%
-33.3%
Q3 2022$4,723,491,000
-70.3%
69,158
-80.3%
0.00%
-62.5%
Q2 2022$15,900,438,000
-19.8%
351,624
-9.9%
0.01%0.0%
Q1 2022$19,823,015,000
+12.2%
390,140
+4.4%
0.01%
+14.3%
Q4 2021$17,667,306,000
+162.8%
373,674
+83.2%
0.01%
+133.3%
Q3 2021$6,723,511,000
-49.9%
203,990
-4.0%
0.00%
-50.0%
Q2 2021$13,430,948,000
+456.4%
212,515
+277.7%
0.01%
+500.0%
Q1 2021$2,414,073,000
-35.0%
56,259
-13.4%
0.00%
-50.0%
Q4 2020$3,714,970,000
+84.2%
64,947
-2.9%
0.00%
+100.0%
Q3 2020$2,017,014,000
-5.6%
66,855
+2.2%
0.00%0.0%
Q2 2020$2,136,749,000
+69.6%
65,424
+39.1%
0.00%0.0%
Q1 2020$1,260,228,000
+13.2%
47,041
+29.4%
0.00%0.0%
Q4 2019$1,113,068,000
+43.4%
36,351
+12.8%
0.00%0.0%
Q3 2019$776,132,000
+119.9%
32,218
+131.4%
0.00%
Q2 2019$352,885,00013,9260.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders